54 companies object to OKXICE stock trading plan


Objections cover 54 of the 62 companies in the proposed lineup, blocking listings of their tokenized shares under a US regulatory exemption.
As of 5 November, 54 companies in OKXICE’s proposed lineup of 62 had objected to having tokenized versions of their shares traded on the platform, Fortune said. Reuters reported a total of 22 objectors on 23 October and said OKX and Intercontinental Exchange had planned to tokenize 63 stocks. Companies outside the original lineup have also filed objections.
Under an exemption granted by the US Securities and Exchange Commission, a platform must notify a company before listing tokenized versions of its shares and give it 30 days to object. An objection blocks the listing.
Boeing and ServiceNow joined the objection list on 4 November, a day after Apple, Home Depot and GE Vernova filed objections. An earlier regulatory document included Wells Fargo, Arm Holdings and Intuit among six additional objectors; it did not give their reasons. Wells Fargo and Arm Holdings were outside the original proposed lineup.
OKXICE is a joint venture between cryptocurrency exchange OKX and Intercontinental Exchange, which owns the New York Stock Exchange. OKXICE said it filed with the regulator to launch a platform for trading tokenized US stocks around the clock.
Tokenization creates digital tokens representing stocks that can be traded on a blockchain, a shared digital record. Under the planned design, each token would be backed by an underlying share and represent ownership, rather than merely track a stock’s price.
OKXICE declined to say whether the growing number of objections would affect its planned launch.


Oil must remain in underground caverns to protect their operation. Estimates differ on how much can safely be withdrawn and how much must stay behind.
3 min

Variety reports a $10 million–$12 million asking price for a 30-second spot, plus matching spending on other Disney ads. Access depends on an existing sponsor giving up its slot.
3 min

The U.S. regulator says meeting CMS price-transparency rules does not exempt providers from liability for unfair or deceptive practices under the FTC Act.
2 min
